Wound Healing

Surgical Induced Wounds are largely the most prevalent wound in the world with over 100 Million cases in 2007 while Chronic Wounds (including pressure, venous and diabetic ulcers, account for about other 30 Million cases in the world according to a MedMarket Diligence study. According do Business Insights report data, almost 178 Million people suffers from skin infections in the major 7 markets, this amount raise to over 700 Million if HSV-1 and HSV-2 are included.

Our patented Nano-Technology electrolytic process enables production of Pure and Stable HClO (Hypoclorous Acid) in a liquid carrier (Bio'n), where all the most important parameters are balanced and optimized in order to obtain one of the best formulation in terms of Efficacy and Safety so maximizing its disinfectant and tissue regenerating properties.

HClO is produced by human immune system as protective agent against infectious pathogens, including bacteria, viruses, yeasts and some fungi and it is also one of the primary driver in any tissue regeneration, wound healing process Bio'n is under investigation chronic and acute infected wounds, the first tests on the Product showed much promising results.